Ticker
XERSCompany Name
XERIS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 59.28M | $ 257.22M | $ 1.26B | $ 1.07B |
3/31/2025 | $ 58.44M | $ 268.75M | $ 1.04B | $ 826.4M |
12/31/2024 | $ 71.62M | $ 271.45M | $ 835.6M | $ 635.77M |
9/30/2024 | $ 59.23M | $ 270.96M | $ 729.05M | $ 517.31M |
6/30/2024 | $ 57.6M | $ 269.8M | $ 544.47M | $ 332.27M |
3/31/2024 | $ 62.69M | $ 268.69M | $ 484.73M | $ 278.72M |
12/31/2023 | $ 67.45M | $ 229.19M | $ 510.07M | $ 348.32M |
9/30/2023 | $ 46.14M | $ 227.94M | $ 431.11M | $ 249.31M |
6/30/2023 | $ 46.17M | $ 224.99M | $ 535.03M | $ 356.21M |
3/31/2023 | $ 50.98M | $ 198.42M | $ 522.29M | $ 374.86M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap + Debt - CashnEq
(=) EV
EV for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: Market Cap [ $ 281.12M ] + Debt [ $ 119.39M ] - CashnEq [ $ 37.89M ]
(=) EV [ $ 362.63M ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.33K |
---|---|
min | $ -1.69B |
max | $ 6.81B |
average | $ 1.25B |
median | $ 438.06M |
std | $ 1.66B |